ID   AHP1_YEAST              Reviewed;         176 AA.
AC   P38013; D6VYA9;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   28-JAN-2026, entry version 223.
DE   RecName: Full=Peroxiredoxin AHP1 {ECO:0000305};
DE            Short=Prx;
DE            EC=1.11.1.24 {ECO:0000269|PubMed:10391912, ECO:0000269|PubMed:9888818};
DE   AltName: Full=Alkyl hydroperoxide reductase {ECO:0000303|PubMed:9988687};
DE            Short=AHPC1;
DE   AltName: Full=Cytoplasmic thiol peroxidase 3 {ECO:0000303|PubMed:10681558};
DE            Short=cTPx 3 {ECO:0000303|PubMed:10681558};
DE   AltName: Full=Thiol-specific antioxidant II {ECO:0000303|PubMed:10681558};
DE            Short=TSA II {ECO:0000303|PubMed:10681558};
DE   AltName: Full=Thioredoxin peroxidase type II {ECO:0000303|PubMed:9888818};
DE            Short=TPx type II;
DE   AltName: Full=Thioredoxin-dependent peroxiredoxin AHP1 {ECO:0000305};
GN   Name=AHP1 {ECO:0000303|PubMed:9988687}; OrderedLocusNames=YLR109W;
GN   ORFNames=L2916, L9354.5;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 90840 / EAY235 / FY23;
RX   PubMed=9090053;
RX   DOI=10.1002/(sici)1097-0061(19970315)13:3<241::aid-yea61>3.0.co;2-#;
RA   Verhasselt P., Volckaert G.;
RT   "Sequence analysis of a 37.6 kbp cosmid clone from the right arm of
RT   Saccharomyces cerevisiae chromosome XII, carrying YAP3, HOG1, SNR6, tRNA-
RT   Arg3 and 23 new open reading frames, among which several homologies to
RT   proteins involved in cell division control and to mammalian growth factors
RT   and other animal proteins are found.";
RL   Yeast 13:241-250(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169871; DOI=10.1038/387s087;
RA   Johnston M., Hillier L.W., Riles L., Albermann K., Andre B., Ansorge W.,
RA   Benes V., Brueckner M., Delius H., Dubois E., Duesterhoeft A.,
RA   Entian K.-D., Floeth M., Goffeau A., Hebling U., Heumann K.,
RA   Heuss-Neitzel D., Hilbert H., Hilger F., Kleine K., Koetter P., Louis E.J.,
RA   Messenguy F., Mewes H.-W., Miosga T., Moestl D., Mueller-Auer S.,
RA   Nentwich U., Obermaier B., Piravandi E., Pohl T.M., Portetelle D.,
RA   Purnelle B., Rechmann S., Rieger M., Rinke M., Rose M., Scharfe M.,
RA   Scherens B., Scholler P., Schwager C., Schwarz S., Underwood A.P.,
RA   Urrestarazu L.A., Vandenbol M., Verhasselt P., Vierendeels F., Voet M.,
RA   Volckaert G., Voss H., Wambutt R., Wedler E., Wedler H., Zimmermann F.K.,
RA   Zollner A., Hani J., Hoheisel J.D.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XII.";
RL   Nature 387:87-90(1997).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-8; 16-48; 80-102 AND 114-176, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT SER-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RA   Bienvenut W.V., Peters C.;
RL   Submitted (MAY-2005) to UniProtKB.
RN   [5]
RP   PROTEIN SEQUENCE OF 8-15; 33-41; 80-102 AND 125-176, AND URMYLATION.
RX   PubMed=14555475; DOI=10.1128/ec.2.5.930-936.2003;
RA   Goehring A.S., Rivers D.M., Sprague G.F. Jr.;
RT   "Attachment of the ubiquitin-related protein Urm1p to the antioxidant
RT   protein Ahp1p.";
RL   Eukaryot. Cell 2:930-936(2003).
RN   [6]
RP   PROTEIN SEQUENCE OF 16-41; 49-68; 82-96; 114-123 AND 142-150,
RP   POST-TRANSLATIONAL MODIFICATION, DISULFIDE BONDS, CATALYTIC ACTIVITY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9888818; DOI=10.1021/bi9817818;
RA   Jeong J.S., Kwon S.J., Kang S.W., Rhee S.G., Kim K.;
RT   "Purification and characterization of a second type thioredoxin peroxidase
RT   (type II TPx) from Saccharomyces cerevisiae.";
RL   Biochemistry 38:776-783(1999).
RN   [7]
RP   PARTIAL PROTEIN SEQUENCE OF 33-37; 82-96; 126-139 AND 157-170, FUNCTION,
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT.
RX   PubMed=10391912; DOI=10.1074/jbc.274.28.19714;
RA   Verdoucq L., Vignols F., Jacquot J.-P., Chartier Y., Meyer Y.;
RT   "In vivo characterization of a thioredoxin H target protein defines a new
RT   peroxiredoxin family.";
RL   J. Biol. Chem. 274:19714-19722(1999).
RN   [8]
RP   PROTEIN SEQUENCE OF 82-99.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=7895733; DOI=10.1002/elps.11501501210;
RA   Garrels J.I., Futcher B., Kobayashi R., Latter G.I., Schwender B.,
RA   Volpe T., Warner J.R., McLaughlin C.S.;
RT   "Protein identifications for a Saccharomyces cerevisiae protein database.";
RL   Electrophoresis 15:1466-1486(1994).
RN   [9]
RP   FUNCTION.
RX   PubMed=10635552; DOI=10.1271/bbb.63.1871;
RA   Farcasanu I.C., Hirata D., Tsuchiya E., Mizuta K., Miyakawa T.;
RT   "Involvement of thioredoxin peroxidase type II (Ahp1p) of Saccharomyces
RT   cerevisiae in Mn2+ homeostasis.";
RL   Biosci. Biotechnol. Biochem. 63:1871-1881(1999).
RN   [10]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=9988687; DOI=10.1074/jbc.274.8.4537;
RA   Lee J., Spector D., Godon C., Labarre J., Toledano M.B.;
RT   "A new antioxidant with alkyl hydroperoxide defense properties in yeast.";
RL   J. Biol. Chem. 274:4537-4544(1999).
RN   [11]
RP   FUNCTION, INDUCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10681558; DOI=10.1074/jbc.275.8.5723;
RA   Park S.G., Cha M.-K., Jeong W., Kim I.-H.;
RT   "Distinct physiological functions of thiol peroxidase isoenzymes in
RT   Saccharomyces cerevisiae.";
RL   J. Biol. Chem. 275:5723-5732(2000).
RN   [12]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-59, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth phosphoproteome
RT   analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-28 AND SER-116, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19779198; DOI=10.1126/science.1172867;
RA   Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.;
RT   "Global analysis of Cdk1 substrate phosphorylation sites provides insights
RT   into evolution.";
RL   Science 325:1682-1686(2009).
RN   [15]
RP   FUNCTION.
RX   PubMed=20145245; DOI=10.1074/jbc.m109.090142;
RA   Iwai K., Naganuma A., Kuge S.;
RT   "Peroxiredoxin Ahp1 acts as a receptor for alkylhydroperoxides to induce
RT   disulfide bond formation in the Cad1 transcription factor.";
RL   J. Biol. Chem. 285:10597-10604(2010).
RN   [16]
RP   URMYLATION AT LYS-32, AND MUTAGENESIS OF LYS-32.
RX   PubMed=21209336; DOI=10.1073/pnas.1014402108;
RA   Van der Veen A.G., Schorpp K., Schlieker C., Buti L., Damon J.R.,
RA   Spooner E., Ploegh H.L., Jentsch S.;
RT   "Role of the ubiquitin-like protein Urm1 as a noncanonical lysine-directed
RT   protein modifier.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:1763-1770(2011).
RN   [17]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-48 AND LYS-113, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22106047; DOI=10.1002/pmic.201100166;
RA   Starita L.M., Lo R.S., Eng J.K., von Haller P.D., Fields S.;
RT   "Sites of ubiquitin attachment in Saccharomyces cerevisiae.";
RL   Proteomics 12:236-240(2012).
RN   [18]
RP   MUTAGENESIS OF CYS-31 AND CYS-62.
RX   PubMed=32004955; DOI=10.1016/j.redox.2020.101438;
RA   Brachmann C., Kaduhr L., Juedes A., Ravichandran K.E., West J.D., Glatt S.,
RA   Schaffrath R.;
RT   "Redox requirements for ubiquitin-like urmylation of Ahp1, a 2-Cys
RT   peroxiredoxin from yeast.";
RL   Redox Biol. 30:101438-101438(2020).
RN   [19]
RP   SULFHYDRATION AT CYS-62 AND CYS-120, UBIQUITINATION AT LYS-81, SUMOYLATION
RP   AT LYS-156, URMYLATION AT LYS-32; LYS-48; LYS-79; LYS-81; LYS-107; LYS-124
RP   AND LYS-156, AND MUTAGENESIS OF CYS-31 AND CYS-62.
RX   PubMed=36102610; DOI=10.15252/embj.2022111318;
RA   Ravichandran K.E., Kaduhr L., Skupien-Rabian B., Shvetsova E.,
RA   Sokolowski M., Krutyholowa R., Kwasna D., Brachmann C., Lin S.,
RA   Guzman Perez S., Wilk P., Koesters M., Grudnik P., Jankowska U.,
RA   Leidel S.A., Schaffrath R., Glatt S.;
RT   "E2/E3-independent ubiquitin-like protein conjugation by Urm1 is directly
RT   coupled to cysteine persulfidation.";
RL   EMBO J. 41:e111318-e111318(2022).
RN   [20]
RP   3D-STRUCTURE MODELING, AND STRUCTURE BY NMR.
RX   PubMed=14640681; DOI=10.1021/bi035551r;
RA   Trivelli X., Krimm I., Ebel C., Verdoucq L., Prouzet-Mauleon V.,
RA   Chartier Y., Tsan P., Lauquin G., Meyer Y., Lancelin J.-M.;
RT   "Characterization of the yeast peroxiredoxin Ahp1 in its reduced active and
RT   overoxidized inactive forms using NMR.";
RL   Biochemistry 42:14139-14149(2003).
RN   [21] {ECO:0007744|PDB:4DSQ, ECO:0007744|PDB:4DSR, ECO:0007744|PDB:4DSS}
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) IN COMPLEX WITH TRX2, ACTIVE SITE,
RP   DISULFIDE BOND, SUBUNIT, AND MUTAGENESIS OF CYS-31; CYS-62 AND CYS-120.
RX   PubMed=22474296; DOI=10.1074/jbc.m112.357368;
RA   Lian F.M., Yu J., Ma X.X., Yu X.J., Chen Y., Zhou C.Z.;
RT   "Structural snapshots of yeast alkyl hydroperoxide reductase Ahp1
RT   peroxiredoxin reveal a novel two-cysteine mechanism of electron transfer to
RT   eliminate reactive oxygen species.";
RL   J. Biol. Chem. 287:17077-17087(2012).
RN   [22] {ECO:0007744|PDB:4H86}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS).
RA   Liu M., Wang F., Qiu R., Wu T., Gu S., Tang R., Ji C.;
RT   "Crystal structure of Ahp1 from Saccharomyces cerevisiae in reduced form.";
RL   Submitted (SEP-2012) to the PDB data bank.
RN   [23] {ECO:0007744|PDB:4OWY}
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS), AND DISULFIDE BONDS.
RA   Schultz L., Genu V., Breyer C.A., dos Santos V.F., Guimaraes B.G.,
RA   de Oliveira M.A., Netto L.E.S.;
RT   "Crystal structure of Ahp1 from Saccharomyces cerevisiae. Investigating the
RT   electron transfers.";
RL   Submitted (FEB-2014) to the PDB data bank.
RN   [24] {ECO:0007744|PDB:7BVV}
RP   X-RAY CRYSTALLOGRAPHY (2.12 ANGSTROMS), AND DISULFIDE BONDS.
RX   PubMed=32531362; DOI=10.1016/j.ijbiomac.2020.06.065;
RA   Lian F.M., Jiang Y.L., Yang W., Yang X.;
RT   "Crystal structure of sulfonic peroxiredoxin Ahp1 in complex with
RT   thioredoxin Trx2 mimics a conformational intermediate during the catalytic
RT   cycle.";
RL   Int. J. Biol. Macromol. 161:1055-1060(2020).
CC   -!- FUNCTION: Thiol-specific peroxidase that catalyzes the reduction of
CC       hydrogen peroxide and organic hydroperoxides to water and alcohols,
CC       respectively. Plays a role in cell protection against oxidative stress
CC       by detoxifying peroxides and as sensor of hydrogen peroxide-mediated
CC       signaling events. Preferentially eliminates organic peroxides rather
CC       than hydrogen peroxide (PubMed:10391912, PubMed:10681558,
CC       PubMed:9988687). Relays alkyl hydroperoxides as a signal to the
CC       transcription factor CAD1/YAP2 by inducing the formation of
CC       intramolecular disulfide bonds in CAD1, which causes its nuclear
CC       accumulation and activation (PubMed:20145245). Involved in cellular
CC       Mn(2+) homeostasis (PubMed:10635552). {ECO:0000269|PubMed:10391912,
CC       ECO:0000269|PubMed:10635552, ECO:0000269|PubMed:10681558,
CC       ECO:0000269|PubMed:20145245, ECO:0000269|PubMed:9988687}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a hydroperoxide + [thioredoxin]-dithiol = an alcohol +
CC         [thioredoxin]-disulfide + H2O; Xref=Rhea:RHEA:62620, Rhea:RHEA-
CC         COMP:10698, Rhea:RHEA-COMP:10700, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:29950, ChEBI:CHEBI:30879, ChEBI:CHEBI:35924,
CC         ChEBI:CHEBI:50058; EC=1.11.1.24;
CC         Evidence={ECO:0000269|PubMed:10391912, ECO:0000269|PubMed:9888818};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=150 uM for H(2)O(2) {ECO:0000269|PubMed:9888818};
CC         KM=14 uM for H(2)O(2) {ECO:0000269|PubMed:10391912};
CC         KM=8 uM for cumene hydroperoxide {ECO:0000269|PubMed:9888818};
CC         KM=45 uM for tert-butyl hydroperoxide {ECO:0000269|PubMed:9888818};
CC         KM=76.9 uM for tert-butyl hydroperoxide
CC         {ECO:0000269|PubMed:22474296};
CC         KM=3 uM for TRX1 {ECO:0000269|PubMed:9888818};
CC         KM=2 uM for TRX2 {ECO:0000269|PubMed:9888818};
CC         KM=1.3 uM for TRX2 {ECO:0000269|PubMed:22474296};
CC         Vmax=20 umol/min/mg enzyme for H(2)O(2) {ECO:0000269|PubMed:9888818};
CC         Vmax=14 umol/min/mg enzyme for cumene hydroperoxide
CC         {ECO:0000269|PubMed:9888818};
CC         Vmax=17 umol/min/mg enzyme for tert-butyl hydroperoxide
CC         {ECO:0000269|PubMed:9888818};
CC         Vmax=17 umol/min/mg enzyme for TRX1 {ECO:0000269|PubMed:9888818};
CC         Vmax=16 umol/min/mg enzyme for TRX2 {ECO:0000269|PubMed:9888818};
CC       pH dependence:
CC         Optimum pH is 6.5. {ECO:0000269|PubMed:9888818};
CC   -!- SUBUNIT: Homodimer; disulfide-linked, upon oxidation.
CC       {ECO:0000269|PubMed:10391912, ECO:0000269|PubMed:22474296,
CC       ECO:0000269|PubMed:9888818, ECO:0000269|PubMed:9988687}.
CC   -!- INTERACTION:
CC       P38013; P34230: PXA2; NbExp=2; IntAct=EBI-2382, EBI-2464632;
CC       P38013; P40150: SSB2; NbExp=2; IntAct=EBI-2382, EBI-8632;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10681558}.
CC   -!- INDUCTION: By H(2)O(2). {ECO:0000269|PubMed:10681558}.
CC   -!- PTM: Conjugated to URM1, a ubiquitin-like protein, in response to
CC       oxidative stresses. The attachment of URM1 to lysine residues
CC       exclusively depends on the presence of a peroxidatic cysteine in the
CC       target protein, with low specificity for the particular residue, motif,
CC       or structural context at which urmylation can occur. The URM1-
CC       conjugation reaction is mechanistically and directly coupled to the
CC       process of cysteine persulfidation, transferring the sulfur atom of the
CC       URM1 thiocarboxyl group to redox-active cysteine residues in the target
CC       protein if it is exposed to oxidative conditions.
CC       {ECO:0000269|PubMed:14555475, ECO:0000269|PubMed:21209336,
CC       ECO:0000269|PubMed:32004955, ECO:0000269|PubMed:36102610}.
CC   -!- PTM: Persulfidated on specific redox-active cysteine residues.
CC       Persulfidation (also called protein S-sulfhydration) may provide a
CC       molecular mechanism that enables cells to protect vulnerable cysteine
CC       residues from reactive oxygen species (ROS) under stress conditions.
CC       {ECO:0000305|PubMed:36102610}.
CC   -!- MISCELLANEOUS: The active site is a conserved redox-active cysteine
CC       residue, the peroxidatic cysteine (C(P)), which makes the nucleophilic
CC       attack on the peroxide substrate. The peroxide oxidizes the C(P)-SH to
CC       cysteine sulfenic acid (C(P)-SOH), which then reacts with another
CC       cysteine residue, the resolving cysteine (C(R)), to form a disulfide
CC       bridge. The disulfide is subsequently reduced by an appropriate
CC       electron donor to complete the catalytic cycle. In this typical 2-Cys
CC       Prx, C(R) is provided by the other dimeric subunit to form an
CC       intersubunit disulfide. The disulfide is subsequently reduced by
CC       thioredoxin. {ECO:0000305|PubMed:22474296}.
CC   -!- MISCELLANEOUS: Present with 16228 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the peroxiredoxin family. Prx5 subfamily.
CC       {ECO:0000305}.
CC   -!- CAUTION: Biochemical and mutational analysis assigned Cys-120 as the
CC       resolving cysteine (C(R)) (PubMed:9888818). However, crystal structures
CC       showed that Cys-120 is deeply buried within the protein and revealed
CC       formation of a disulfide bond between the peroxidatic cysteine Cys-62
CC       and the therefore more likely C(R) Cys-31 (PubMed:22474296, Ref.23).
CC       {ECO:0000305|PubMed:22474296, ECO:0000305|PubMed:9888818,
CC       ECO:0000305|Ref.23}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X89514; CAA61687.1; -; Genomic_DNA.
DR   EMBL; Z73281; CAA97676.1; -; Genomic_DNA.
DR   EMBL; U53878; AAB67554.1; -; Genomic_DNA.
DR   EMBL; BK006945; DAA09425.1; -; Genomic_DNA.
DR   PIR; S64946; S64946.
DR   RefSeq; NP_013210.1; NM_001181996.1.
DR   PDB; 4DSQ; X-ray; 2.40 A; A/B/C/D=1-176.
DR   PDB; 4DSR; X-ray; 2.91 A; A/B/C/D=1-176.
DR   PDB; 4DSS; X-ray; 2.10 A; A=1-176.
DR   PDB; 4H86; X-ray; 2.00 A; A=1-176.
DR   PDB; 4OWY; X-ray; 2.20 A; A/B/C/D=1-176.
DR   PDB; 7BVV; X-ray; 2.12 A; A=1-176.
DR   PDBsum; 4DSQ; -.
DR   PDBsum; 4DSR; -.
DR   PDBsum; 4DSS; -.
DR   PDBsum; 4H86; -.
DR   PDBsum; 4OWY; -.
DR   PDBsum; 7BVV; -.
DR   AlphaFoldDB; P38013; -.
DR   BMRB; P38013; -.
DR   SMR; P38013; -.
DR   BioGRID; 31382; 140.
DR   DIP; DIP-6375N; -.
DR   FunCoup; P38013; 767.
DR   IntAct; P38013; 47.
DR   MINT; P38013; -.
DR   STRING; 4932.YLR109W; -.
DR   iPTMnet; P38013; -.
DR   PaxDb; 4932-YLR109W; -.
DR   PeptideAtlas; P38013; -.
DR   TopDownProteomics; P38013; -.
DR   EnsemblFungi; YLR109W_mRNA; YLR109W; YLR109W.
DR   GeneID; 850799; -.
DR   KEGG; sce:YLR109W; -.
DR   AGR; SGD:S000004099; -.
DR   SGD; S000004099; AHP1.
DR   VEuPathDB; FungiDB:YLR109W; -.
DR   eggNOG; KOG0541; Eukaryota.
DR   HOGENOM; CLU_072440_1_1_1; -.
DR   InParanoid; P38013; -.
DR   OMA; YTMNGWA; -.
DR   OrthoDB; 1882547at2759; -.
DR   BioCyc; YEAST:YLR109W-MONOMER; -.
DR   Reactome; R-SCE-3299685; Detoxification of Reactive Oxygen Species.
DR   Reactome; R-SCE-5628897; TP53 Regulates Metabolic Genes.
DR   BioGRID-ORCS; 850799; 2 hits in 10 CRISPR screens.
DR   EvolutionaryTrace; P38013; -.
DR   PRO; PR:P38013; -.
DR   Proteomes; UP000002311; Chromosome XII.
DR   RNAct; P38013; protein.
DR   GO; GO:0005737; C:cytoplasm; IDA:SGD.
DR   GO; GO:0005829; C:cytosol; HDA:SGD.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0005777; C:peroxisome; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; HDA:SGD.
DR   GO; GO:0008379; F:thioredoxin peroxidase activity; IDA:SGD.
DR   GO; GO:0045454; P:cell redox homeostasis; IDA:SGD.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IGI:SGD.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; IBA:GO_Central.
DR   GO; GO:0010038; P:response to metal ion; IMP:SGD.
DR   CDD; cd03013; PRX5_like; 1.
DR   FunFam; 3.40.30.10:FF:000316; Peroxiredoxin AHP1; 1.
DR   Gene3D; 3.40.30.10; Glutaredoxin; 1.
DR   InterPro; IPR037944; PRX5-like.
DR   InterPro; IPR013740; Redoxin.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   InterPro; IPR013766; Thioredoxin_domain.
DR   PANTHER; PTHR10430; PEROXIREDOXIN; 1.
DR   PANTHER; PTHR10430:SF16; PEROXIREDOXIN-5, MITOCHONDRIAL; 1.
DR   Pfam; PF08534; Redoxin; 1.
DR   SUPFAM; SSF52833; Thioredoxin-like; 1.
DR   PROSITE; PS51352; THIOREDOXIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Antioxidant; Cytoplasm;
KW   Direct protein sequencing; Disulfide bond; Isopeptide bond; Oxidoreductase;
KW   Peroxidase; Phosphoprotein; Redox-active center; Reference proteome;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|Ref.4"
FT   CHAIN           2..176
FT                   /note="Peroxiredoxin AHP1"
FT                   /id="PRO_0000056610"
FT   DOMAIN          9..176
FT                   /note="Thioredoxin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00691"
FT   ACT_SITE        62
FT                   /note="Cysteine sulfenic acid (-SOH) intermediate"
FT                   /evidence="ECO:0000305|PubMed:22474296"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000269|Ref.4"
FT   MOD_RES         28
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19779198"
FT   MOD_RES         59
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18407956"
FT   MOD_RES         62
FT                   /note="Cysteine persulfide"
FT                   /evidence="ECO:0000269|PubMed:36102610"
FT   MOD_RES         116
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19779198"
FT   MOD_RES         120
FT                   /note="Cysteine persulfide"
FT                   /evidence="ECO:0000269|PubMed:36102610"
FT   DISULFID        31
FT                   /note="Interchain (with C-31 in TRX2); transient"
FT                   /evidence="ECO:0000269|PubMed:22474296,
FT                   ECO:0000269|PubMed:32531362, ECO:0007744|PDB:4DSS,
FT                   ECO:0007744|PDB:7BVV"
FT   DISULFID        31
FT                   /note="Interchain (with C-62); in linked form"
FT                   /evidence="ECO:0000269|PubMed:22474296,
FT                   ECO:0007744|PDB:4DSQ, ECO:0007744|PDB:4OWY"
FT   DISULFID        62
FT                   /note="Interchain (with C-31); in linked form"
FT                   /evidence="ECO:0000269|PubMed:22474296,
FT                   ECO:0007744|PDB:4DSQ, ECO:0007744|PDB:4OWY"
FT   CROSSLNK        32
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in URM1)"
FT                   /evidence="ECO:0000269|PubMed:32004955,
FT                   ECO:0000269|PubMed:36102610, ECO:0000305|PubMed:21209336"
FT   CROSSLNK        48
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0007744|PubMed:22106047"
FT   CROSSLNK        48
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in URM1); alternate"
FT                   /evidence="ECO:0000269|PubMed:36102610"
FT   CROSSLNK        79
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in URM1)"
FT                   /evidence="ECO:0000269|PubMed:36102610"
FT   CROSSLNK        81
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:36102610"
FT   CROSSLNK        81
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in URM1); alternate"
FT                   /evidence="ECO:0000269|PubMed:36102610"
FT   CROSSLNK        107
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in URM1)"
FT                   /evidence="ECO:0000269|PubMed:36102610"
FT   CROSSLNK        113
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0007744|PubMed:22106047"
FT   CROSSLNK        124
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in URM1)"
FT                   /evidence="ECO:0000269|PubMed:36102610"
FT   CROSSLNK        156
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT                   /evidence="ECO:0000269|PubMed:36102610"
FT   CROSSLNK        156
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in URM1); alternate"
FT                   /evidence="ECO:0000269|PubMed:32004955,
FT                   ECO:0000269|PubMed:36102610"
FT   MUTAGEN         31
FT                   /note="C->S: Abolishes catalytic activity, but does not
FT                   impact URM1 conjugation."
FT                   /evidence="ECO:0000269|PubMed:22474296,
FT                   ECO:0000269|PubMed:32004955, ECO:0000269|PubMed:36102610"
FT   MUTAGEN         32
FT                   /note="K->R: Prevents urmylation of AHP1."
FT                   /evidence="ECO:0000269|PubMed:21209336"
FT   MUTAGEN         62
FT                   /note="C->S: Abolishes catalytic activity, and completely
FT                   abolishes URM1 conjugation."
FT                   /evidence="ECO:0000269|PubMed:22474296,
FT                   ECO:0000269|PubMed:32004955, ECO:0000269|PubMed:36102610"
FT   MUTAGEN         120
FT                   /note="C->S: No effect on tert-butyl hydroperoxide
FT                   consumption."
FT                   /evidence="ECO:0000269|PubMed:22474296"
FT   CONFLICT        21
FT                   /note="I -> T (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        65
FT                   /note="S -> V (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        87
FT                   /note="I -> E (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   TURN            3..6
FT                   /evidence="ECO:0007829|PDB:4H86"
FT   STRAND          15..18
FT                   /evidence="ECO:0007829|PDB:4H86"
FT   STRAND          23..25
FT                   /evidence="ECO:0007829|PDB:4H86"
FT   STRAND          26..28
FT                   /evidence="ECO:0007829|PDB:4OWY"
FT   HELIX           29..31
FT                   /evidence="ECO:0007829|PDB:4H86"
FT   STRAND          35..38
FT                   /evidence="ECO:0007829|PDB:4H86"
FT   HELIX           39..45
FT                   /evidence="ECO:0007829|PDB:4H86"
FT   STRAND          47..53
FT                   /evidence="ECO:0007829|PDB:4H86"
FT   HELIX           60..64
FT                   /evidence="ECO:0007829|PDB:4H86"
FT   HELIX           67..80
FT                   /evidence="ECO:0007829|PDB:4H86"
FT   STRAND          85..92
FT                   /evidence="ECO:0007829|PDB:4H86"
FT   HELIX           94..103
FT                   /evidence="ECO:0007829|PDB:4H86"
FT   STRAND          110..116
FT                   /evidence="ECO:0007829|PDB:4H86"
FT   HELIX           118..120
FT                   /evidence="ECO:0007829|PDB:4H86"
FT   HELIX           121..125
FT                   /evidence="ECO:0007829|PDB:4H86"
FT   STRAND          129..133
FT                   /evidence="ECO:0007829|PDB:4H86"
FT   STRAND          136..139
FT                   /evidence="ECO:0007829|PDB:4H86"
FT   STRAND          141..147
FT                   /evidence="ECO:0007829|PDB:4H86"
FT   STRAND          150..156
FT                   /evidence="ECO:0007829|PDB:4H86"
FT   TURN            160..162
FT                   /evidence="ECO:0007829|PDB:4H86"
FT   HELIX           169..173
FT                   /evidence="ECO:0007829|PDB:4H86"
SQ   SEQUENCE   176 AA;  19115 MW;  11B730781306A015 CRC64;
     MSDLVNKKFP AGDYKFQYIA ISQSDADSES CKMPQTVEWS KLISENKKVI ITGAPAAFSP
     TCTVSHIPGY INYLDELVKE KEVDQVIVVT VDNPFANQAW AKSLGVKDTT HIKFASDPGC
     AFTKSIGFEL AVGDGVYWSG RWAMVVENGI VTYAAKETNP GTDVTVSSVE SVLAHL
//
